CEMATRIX CEO Jeff Kendrick joined Proactive's Steve Darling to share news about the company that manufactures and supplies cellular concrete products developed from proprietary formulations for cement-based material.
CEMATRIX's cellulite concrete finds applications in backfilling overpasses, bridge abutments, tunnels, utility installations, and road underlays in unstable or seismic-prone soils. The company does not replace regular concrete but provides a better and cost-effective solution compared to other support materials.
Kendrick told Proactive that CEMATRIX has seen continued success in business development this year with $5.9 million in new contracts. Kendrick said they have a backlog in contracts and $38.2 million of the current backlog is scheduled for 2023.